Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by Eoj123on Feb 11, 2020 8:29pm
126 Views
Post# 30677522

RE:RE:RE:RE:RE:RE:RE:RE: I give them a maximum of 6 weeks

RE:RE:RE:RE:RE:RE:RE:RE: I give them a maximum of 6 weeks
V.GENE 

 

(TheNewswire)

Vancouver, BC / TheNewswire / December 5, 2016 - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it has paid a $1 million dividend to shareholders as of record on November 21, 2016.

 

Dan Kriznic, CEO commented “The payment of this dividend marks a milestone in our overall strategy of acquiring cannabis assets and ultimately exiting at a much greater valuation. In the past 12 months we divested of three assets for approximately $5.4 million. Invictus MD’s cost base on those assets was $1.3 million representing a 315% return on investment. We continue to seek opportunities that will harvest similar results. The recent $12 million financing gives us the necessary capital to execute on our North American cannabis acquisition plan. ”

 

About Invictus MD Strategies Corp.

Invictus MD targets cannabis companies with proven brands, strong customer focus, and significant growth potential.  We provide not only capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business, from establishing start-ups to running large international organizations.  The fundamental core of our operations centers on the vast opportunities within fragmented industries.  

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth.  Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information, please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

604-368-6437




<< Previous
Bullboard Posts
Next >>